Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Nov 8, 2022 · 10-Q · 39 days after period end · 0001640334-22-002363
| Metric | Q3 2022 | Q3 2021 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$2.33M | -$2.25M | -$344.88K | -$577.86K |
| EPS Diluted | — | — | -$0.40 | -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end
